Second hip fracture and patients' medication after the first hip fracture: A follow-up of 221 hip fracture patients in Finland

Archives of Gerontology and Geriatrics

Volumn 52, Issue 2, 2011, Pages 185-189

  Kaukonen, Juha Pekka ^a   Lüthje, Peter ^b   Nurmi Lüthje, Ilona ^c,d   Kataja, Matti ^e   Naboulsi, Helena ^a  

^a PÄIJÄT HÄME CENTRAL HOSPITAL   (Finland)

^b Kuusankosken Aluesairaala   (Finland)

^c UNIVERSITY OF HELSINKI   (Finland)

^d Health Centre of Kouvola   (Finland)

^e NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

Author keywords

Hip fractures; Medication after the first hip fraction; Second hip fractures

Indexed keywords

ANALGESIC AGENT; ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; CALCIUM; CARDIAC AGENT; CORTICOSTEROID; PSYCHOTROPIC AGENT; THIAZIDE DIURETIC AGENT; VITAMIN D;

ADULT; AGED; ARTICLE; CERVICAL SPINE FRACTURE; DRUG USE; FEMALE; FEMUR SUBTROCHANTERIC FRACTURE; FEMUR TROCHANTERIC FRACTURE; FINLAND; FOLLOW UP; HIP FRACTURE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PRACTICE GUIDELINE; PRIORITY JOURNAL;

ACCIDENTAL FALLS; AGED; AGED, 80 AND OVER; BONE DENSITY CONSERVATION AGENTS; CALCIUM; DIETARY SUPPLEMENTS; FEMALE; FINLAND; FOLLOW-UP STUDIES; HIP FRACTURES; HUMANS; INCIDENCE; MALE; MIDDLE AGED; POLYPHARMACY; PSYCHOTROPIC DRUGS; RECURRENCE; RISK FACTORS; VITAMIN D;

EID: 79551584973     PISSN: 01674943     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.archger.2010.03.015     Document Type: Article

References (50)

1. Bartlett G., Abrahamowicz M., Grad R., Sylvestre M.P., Tamblyn R. Association between risk factors for injurious falls and new benzodiazepine prescribing in elderly persons. BMC Fam. Pract. 2009, 10:1. 10.1186/1471-2296-10-1.
2. Berry S.D., Samelson E.J., Hannan M.T., McLean R.R., Lu M., Cupples L.A., Shaffer M.L., Beiser A.L., Kelly-Hayes M., Kiel D.P. Second hip fracture in older men and women. The Framingham study. Arch. Int. Med. 2007, 167:1971-1976.
3. Bischoff-Ferrari H.A., Dawson-Hughes B., Staehelin H.B., Orav J.E., Stuck A.E., Theiler R., Wong J.B., Egli A., Kiel D.P., Henschkowski J. Fall prevention with supplemental and active forms of vitamin D: a meta-analysis of randomised controlled trials. Br. Med. J. 2009, 339. 10.1136/bmj.b.3692.
4. Cadarette S.M., Katz J.N., Brookhart M.A., Levin R., Stedman M.R., Choudhry N.K., Solomon D.H. Trends in drug prescribing for osteoporosis after hip fracture, 1995-2004. J. Rheumatol. 2008, 35:319-326.
5. Capeci C.M., Tejwani N.C. Bilateral low-energy simultaneous or sequential femoral fractures in patients on long-term alendronate therapy. J. Bone Surg. Am. 2009, 91:2556-2561.
6. Chapurlat R.D., Bauer D.C., Newitt M., Stone K., Cummings S.R. Incidence and risk factors for a second hip fracture in elderly women. The study of osteoporotic fractures. Osteoporos. Int. 2003, 14:130-136.
7. Chiu K.Y., Pun W.K., Luk K.D., Chow S.P. Sequential fractures of both hips in elderly patients-a prospective study. J. Trauma 1992, 32:584-587.
8. Currie C.T., Hutchison J.D. Audit, guidelines and standards: clinical governance for hip fracture care in Scotland. Disabil. Rehabil. 2005, 27:1099-1105.
9. Davis C.D., Ashe M.C., Guy P., Khan K.M. Undertreatment after hip fracture: a retrospective study of osteoporosis overlooked. J. Am. Geriatr. Soc. 2006, 47:651-654.
10. Dell R.M., Greene D., Anderson D., Williams K. Osteoporosis disease management: what every orthopaedic surgeon should know. J. Bone Joint Surg. Am. 2009, 91(Suppl. 6):79-86.
11. Dretakis K.E., Dretakis E.K., Papakitsou E.F., Psarakis S., Steriopoulos K. Possible predisposing factors for the second hip fracture. Calcif. Tissue Int. 1998, 62:366-369.
12. Dvorak M.M., Joussineau C.D., Carter D.H., Pisitkun T., Knepper M.A., Gamba G., Kemp P.J., Riccardi D. Thiazide diuretics directly induce osteoblast differentiation and mineralized nodule formation by interacting with a sodium chloride co-transporter in bone. J. Am. Soc. Nephrol. 2007, 18:2509-2516.
13. Edwars B.J., Bunta A.D., Simonelli C., Bolander M., Fitzpatrick L.A. Prior fractures are common in patients with subsequent hip fractures. Clin. Orthop. Relat. Res. 2007, 461:226-230.
14. Egan M., Jaglal S., Byrne K., Wells J., Stolee P. Factors associated with a second hip fracture: a systematic review. Clin. Rehabil. 2008, 22:272-282.
15. Fukushima T., Sudo A., Uchida A. Bilateral hip fractures. J. Orthop. Sci. 2006, 11:435-438.
16. Green J.L., Hawley J.N., Rask K.J. Is the number of prescribing physicians an independent risk factor for adverse drug events in an elderly outpatient population?. Am. J. Geriatr. Pharmacother. 2007, 5:31-39.
17. Hegeman J., Van den Bemt B.J., Duysens J., Van Limbeek J. NSAIDs and the risk of accidental falls in the elderly: a systematic review. Drug Saf. 2009, 32:489-498.
18. Huang K.C., Ku M.C., Lee T.S. Second hip fracture. Zhonghua Yi Xue Za Zhi 1992, 50:149-152.
19. Jyrkkä J., Vartiainen L., Hartikainen S., Sulkava R., Enlund H. Increasing use of medicines in elderly persons: a five-year follow-up of the Kuopio 75+ study. Eur. J. Clin. Pharmacol. 2006, 62:151-158.
20. Jörgensen T., Johansson S., Kennerfalk A., Wallander M.A., Svärdsudd K. Prescription drug use, diagnoses, and healthcare utilization among the elderly. Ann. Pharmacother. 2001, 35:1004-1009.
21. Kanis J.A., Burlet N., Cooper C., Delmas P.D., Reginster J.-Y., Borgstrom F., Rizzoli R. European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos. Int. 2008, 19:399-428.
22. Kaper B.P., Mayor M.B. Incidence of bilateral proximal femur fractures in a tertiary care center. Orthopedics 2001, 24:571-574.
23. Kaukonen J.-P., Nurmi-Lüthje I., Lüthje P., Naboulsi H., Tanninen S., Kataja M., Kallio M.-L., Leppilampi M. Acute alcohol use among patients with acute hip fractures. A descriptive incidence study in Southeastern Finland. Alcohol Alcohol. 2006, 41:345-348.
24. Kuijpers M.A., Van Marum R.J., Egberts A.C., Jansen P.A. Relationship between polypharmacy and underprescribing. Br. J. Clin. Pharmacol. 2008, 65:130-133.
25. Linjakumpu T., Hartikainen S., Klaukka T., Veijola J., Kivelä S.L., Isoaho R. Use of medications and polypharmacy are increasing among the elderly. J. Clin. Epidemiol. 2002, 55:809-817.
26. Linton A., Garber M., Fagan N.K., Peterson M. Examination of multiple medication use among TRICARE beneficiaries aged 65 years and older. J. Manage. Care Pharm. 2007, 13:155-162.
27. Lönnroos E., Kautiainen H., Karppi P., Hartikainen S., Kiviranta I., Sulkava R. Incidence of second hip fractures. A population based study. Osteoporos. Int. 2007, 18:1279-1285.
28. Lüthje P., Nurmi-Lüthje I., Kaukonen J.-P., Kuurne S., Naboulsi H., Kataja M. Undertreatment of osteoporosis following hip fracture in the elderly. Arch. Gerontol. Geriatr. 2009, 49:153-157.
29. Lyles K.W., Colón-Emeric C.S., Magaziner J.S., Adachi J.D., Pieper C.F., Mautalen C., Hyldstrup L., Recknor C., Nordsletten L., Moore K.A., Lavecchia C., Zhang J., Mesenbrink P., Hodgson P.K., Abrams K., Orloff J.J., Horowitz Z., Eriksen E.F., Boonen S. HORIZON recurrent fracture trial. Zoledronic acid and clinical fractures and mortality after hip fracture. N. Engl. J. Med. 2007, 357:1799-1809.
30. Melton L.J., Kearns A.E., Atkinson E.J., Bolander M.E., Achenbach S.J., Hudd-leston J.M., Therneau T.M., Leibson C.L. Secular trends in hip fracture incidence and recurrence. Osteoporos. Int. 2009, 20:687-694.
31. National Guidelines Treatment of hip fracture patients. Duodecim 2006, 122:358-379. (in Finnish). http://www.kaypahopito.fi/.
32. Nurmi I., Kaukonen J.-P., Lüthje P., Naboulsi H., Tanninen S., Kataja M., Kallio M.-L., Leppilampi M. Half of the patients with an acute hip fracture suffer from hypovitaminosis D: a prospective study in South-East of Finland. Osteoporos. Int. 2005, 16:2018-2024.
33. Nurmi-Lüthje I., Kaukonen J.-P., Lüthje P., Naboulsi H., Tanninen S., Kataja M., Kallio M.-L., Leppilampi M. Use of benzodiazepines and benzodiazepine-related drugs among 223 patients with an acute hip fracture in Finland: comparison of benzodiazepine findings in medical records and laboratory findings. Drugs Aging 2006, 23:27-37.
34. Nurmi-Lüthje I., Lüthje P., Kaukonen J.P., Kataja M., Tanninen S., Naboulsi J., Karjalainen K. Post-fracture prescribed calcium and vitamin D supplements alone or, in females, with concomitant anti-osteoporotic drugs is associated with lower mortality among elderly hip fracture patients: a prospective analysis. Drugs Aging 2009, 26:409-421.
35. Nymark T., Lauritzen J.M., Ovesen O., Röck N.D., Jeune B. Short time-frame from first to second hip fracture in the Funen County Hip Fracture Study. Osteoporos. Int. 2006, 17:1353-1357.
36. Pearse E.O., Redfern D.J., Sinha M., Edge A.J. Outcome following a second hip fracture. Injury 2003, 34:518-521.
37. Rabenda V., Vanoverloop J., Fabri V., Mertens R., Sumkay F., Vannecke C., Deswaef A., Verpooten G.A., Reginster J.Y. Low incidence of anti osteoporosis treatment after hip fracture. J. Bone Joint Surg. Am. 2008, 90:2142-2148.
38. Rejnmark L., Vestergaard P., Mosekilde L. Reduced fracture risk in users of thiazide diuretics. Calc. Tissue Int. 2005, 76:167-175.
39. Rodan G., Reszka A., Golub E., Rizzoli R. Bone safety of long-term bisphosphonate treatment. Curr. Med. Res. Opin. 2004, 20:1291-1300.
40. Ryg J., Rejnmark K.L., Overgaard S., Brixen K., Vestergaard P. Hip fracture patients ad risk of second hip fracture: a nationwide population-based cohort study of 169145 cases during 1977-2001. J. Bone Miner. Res. 2009, 24:1299-1307.
41. Saxena P., Shankar J. Contralateral hip fractures-can predisposing factors be determined?. Injury 2000, 31:421-424.
42. Schoofs M.W., Van der Klift M., Hofman A., De Laet C.E., Herings R.M., Stijnen T., Pols H.A., Stricker B.H. Thiazide diuretics and the risk of hip fracture. Ann. Intern. Med. 2003, 139:476-482.
43. Schrøder H.M., Petersen K.K., Erlandsen M. Occurrence and incidence of the second hip fracture. Clin. Orthop. Relat. Res. 1993, 289:166-169.
44. Shabat S., Gepstein R., Mann G., Kish B., Fredman B., Nyska M. The second hip fracture-an analysis of 84 elderly patients. J. Orthop. Trauma 2003, 17:613-617.
45. Stewart A., Walker L.G., Porter R.W., Reid D.M., Primrose W.R. Predicting a second hip fracture. J. Clin. Densitom. 1999, 2:363-370.
46. Vestergaard P., Rejnmark L., Mosekilde L. Fracture risk associated with the use of morphine and opiates. J. Intern. Med. 2006, 260:76-87.
47. Wolinsky F.D., Fitzgerald J.F. Subsequent hip fracture among older adults. Am. J. Public Health 1994, 84:1316-1318.
48. Yamanashi A., Yamazaki K., Kanamori M., Mochizuki K., Okamoto S., Koide Y., Kin K., Nagano A. Assessment of risk factors for second hip fractures in Japanese elderly. Osteoporos. Int. 2005, 16:1239-1246.
49. Youde J., Husk J., Lowe D., Grant R., Potter J., Martin F. The national clinical audit of falls and bone health: the clinical management of hip fracture patients. Injury 2009, 40:1226-1230.
50. Ziere G., Dieleman J.P., Hofman A., Pols H.A., Van der Cammen T.J., Stricker B.H. Polypharmacy and falls in the middle age and elderly population. Br. J. Clin. Pharmacol. 2006, 61:218-223.